NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Kemper AR, Coeytaux R, Sanders GD, et al. Disease-Modifying Antirheumatic Drugs (DMARDs) in Children With Juvenile Idiopathic Arthritis (JIA) [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Sep. (Comparative Effectiveness Reviews, No. 28.)
This publication is provided for historical reference only and the information may be out of date.
Disease-Modifying Antirheumatic Drugs (DMARDs) in Children With Juvenile Idiopathic Arthritis (JIA) [Internet].
Show details- ACR
American College of Rheumatology
- ACR Pediatric
American College of Rheumatology Pediatric Response Criteria
- AHRQ
Agency for Healthcare Research and Quality
- AJC
Active joint count
- CD
Cluster of differentiation
- CHAQ
Childhood Health Assessment Questionnaire
- CHAQ-DI
Childhood Health Assessment Questionnaire Disability Index
- CHQ
Child Health Questionnaire
- CHQ PhS
Child Health Questionnaire physical score
- CHQ PsS
Child Health Questionnaire psychosocial score
- CI
Confidence interval
- DMARD(s)
Disease-modifying antirheumatic drug(s)
- EPC
Evidence-based Practice Center
- ESR
Erythrocyte sedimentation rate
- EULAR
European League Against Rheumatism
- Fc
Fragment crystallizable
- FDA
U.S. Food and Drug Administration
- GRADE
Grading of Recommendations Assessment, Development and Evaluation
- HAQ
Stanford Health Assessment Questionnaire
- IgM
Immunoglobulin M
- IL
Interleukin
- ILAR
International League of Associations for Rheumatology
- IVIG
Intravenous immunoglobulin
- JCA
Juvenile chronic arthritis
- JADAS
Juvenile Arthritis Disease Activity Score (JADAS)
- JIA
Juvenile idiopathic arthritis
- JRA
Juvenile rheumatoid arthritis
- LROM
Limited range of motion
- MDA
Minimal disease activity
- MeSH
Medical Subject Headings
- NSAID(s)
Non-steroidal anti-inflammatory drug(s)
- PedsQL
Pediatric Quality of Life Inventory
- PedsQL-RM
Pediatric Quality of Life Inventory Rheumatology Module
- PGA
Physician global assessment of disease activity
- PGW
Parent/patient global assessment of well-being
- PICOTS
Population, interventions, comparators of interest, outcomes, timing, settings
- RCT
Randomized controlled trial
- ROC
Receiver operating characteristic
- RR
Risk ratio
- SAARD(s)
Slow-acting antirheumatic drug(s)
- SRC
Scientific Resource Center
- T-cell/-lymphocyte
Thymus cell/lymphocyte
- TEP
Technical expert panel
- TNF
Tumor necrosis factor
- Abbreviations - Disease-Modifying Antirheumatic Drugs (DMARDs) in Children With ...Abbreviations - Disease-Modifying Antirheumatic Drugs (DMARDs) in Children With Juvenile Idiopathic Arthritis (JIA)
Your browsing activity is empty.
Activity recording is turned off.
See more...